JP2009541373A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009541373A5 JP2009541373A5 JP2009516901A JP2009516901A JP2009541373A5 JP 2009541373 A5 JP2009541373 A5 JP 2009541373A5 JP 2009516901 A JP2009516901 A JP 2009516901A JP 2009516901 A JP2009516901 A JP 2009516901A JP 2009541373 A5 JP2009541373 A5 JP 2009541373A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- adjuvant
- peptide
- protein
- vaccine according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200600861 | 2006-06-28 | ||
| DKPA200600861 | 2006-06-28 | ||
| PCT/DK2007/000312 WO2008000261A2 (en) | 2006-06-28 | 2007-06-26 | Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009541373A JP2009541373A (ja) | 2009-11-26 |
| JP2009541373A5 true JP2009541373A5 (enExample) | 2010-07-29 |
| JP5165681B2 JP5165681B2 (ja) | 2013-03-21 |
Family
ID=38845996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009516901A Expired - Fee Related JP5165681B2 (ja) | 2006-06-28 | 2007-06-26 | タンパク質断片又はペプチドカクテルとして送達される抗原を用いたワクチン接種によるサブドミナントエピトープを含むｔ細胞レパートリーの拡大 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8105614B2 (enExample) |
| EP (3) | EP2402024A1 (enExample) |
| JP (1) | JP5165681B2 (enExample) |
| KR (1) | KR20090024292A (enExample) |
| AU (1) | AU2007264205B2 (enExample) |
| BR (1) | BRPI0713978A2 (enExample) |
| CA (1) | CA2654271A1 (enExample) |
| DK (1) | DK2040745T3 (enExample) |
| ES (1) | ES2400531T3 (enExample) |
| RU (1) | RU2490024C2 (enExample) |
| WO (1) | WO2008000261A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2333073T3 (es) * | 1998-11-04 | 2010-02-16 | Isis Innovation Limited | Prueba diagnostica de tuberculosis. |
| WO2004006952A2 (en) * | 2002-07-13 | 2004-01-22 | Statens Serum Institut | Therapeutic tuberculosis vaccines |
| MX2009013008A (es) * | 2007-05-31 | 2010-06-09 | Vacunas para la influenza. | |
| US8563009B2 (en) * | 2007-06-29 | 2013-10-22 | Statens Serum Institut | Use of monomycolyl glycerol (MMG) as an adjuvant |
| ES2588705T3 (es) | 2007-09-27 | 2016-11-04 | Immunovaccine Technologies Inc. | Uso de liposomas en un vehículo que comprende una fase hidrófoba continua para la entrega de polinucleótidos in vivo |
| CA2723918C (en) * | 2008-06-05 | 2018-01-09 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| US20100015171A1 (en) | 2008-07-15 | 2010-01-21 | Statens Serum Institute | Vaccines comprising tb 10.4 |
| ES2614802T3 (es) * | 2008-11-28 | 2017-06-02 | Statens Serum Institut | Vacunas contra la gripe optimizadas |
| TR201903223T4 (tr) * | 2009-04-24 | 2019-03-21 | Statens Seruminstitut | Reaktivasyonu önlemek üzere bir tüberküloz TB aşısı. |
| CA3002946C (en) * | 2009-11-05 | 2021-11-02 | The United States Of America As Represented By The Secretary Of The Navy | Plasmodium falciparum sporozoite and liver stage antigens |
| WO2011063133A1 (en) * | 2009-11-18 | 2011-05-26 | Auburn University | LOW ANTIGEN-DOSE IMMUNIZATION FOR MAXIMIZING T-HELPER CELL 1 (T h1) IMMUNITY AGAINST DISEASE |
| US20120244178A1 (en) * | 2011-03-25 | 2012-09-27 | Denise Doolan | Plasmodium falciparum antigens |
| US10286050B2 (en) | 2013-12-13 | 2019-05-14 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Multi-epitope TARP peptide vaccine and uses thereof |
| BR112016023778A2 (pt) | 2014-04-24 | 2017-10-17 | Statens Seruminstitut | proteína de fusão ou coquetel antígeno, uso de uma proteína de fusão ou coquetel antígeno, vacina, e método para a imunização de um animal, incluindo um ser humano, contra a tuberculose causada por micobactérias virulentas |
| CN117064854A (zh) * | 2023-08-14 | 2023-11-17 | 广州谦毅生物医药有限公司 | 一种卡瓦脂质体的制备技术 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4599231A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4608251A (en) | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
| US4601903A (en) | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
| US4975282A (en) | 1985-06-26 | 1990-12-04 | The Liposome Company, Inc. | Multilamellar liposomes having improved trapping efficiencies |
| US6641814B1 (en) * | 1997-04-02 | 2003-11-04 | Statens Serum Institut | Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis |
| CA2175692A1 (en) * | 1993-11-04 | 1995-05-11 | Geert Leroux-Roels | Immunodominant human t-cell epitopes of hepatitis c virus |
| BR9909472A (pt) * | 1998-04-07 | 2001-09-11 | Corixa Corp | Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica |
| US6649170B1 (en) | 1999-05-12 | 2003-11-18 | Statens Serum Institut | Adjuvant combinations for immunization composition and vaccines |
| SE9903031D0 (sv) | 1999-08-27 | 1999-08-27 | Eurodiagnostica Ab | Peptide mixture and vaccine against a chronic viral infection |
| EP1229931A4 (en) * | 1999-10-07 | 2003-05-28 | Corixa Corp | FUSION PROTEINS FROM MYCOBACTERIUM TUBERCULOSIS |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| DE60100814T2 (de) | 2000-06-08 | 2004-07-01 | Intercell Biomedizinische Forschungs- Und Entwicklungs Gmbh | Immunstimulierende oligodeoxynukleotide |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| GB0118532D0 (en) | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
| AU2003245729A1 (en) * | 2002-06-27 | 2004-01-19 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for modulating a cytotoxic t lymphocyte immune response |
| CN1980638B (zh) * | 2004-07-07 | 2011-10-12 | 国立血清研究所 | 用糖脂稳定基于脂质的佐剂制剂的组合物和方法 |
| US7749520B2 (en) | 2004-07-07 | 2010-07-06 | Statens Serum Institut | Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| FR2873467A1 (fr) | 2004-07-26 | 2006-01-27 | Proton World Internatinal Nv | Enregistrement d'une cle dans un circuit integre |
| PL1991266T3 (pl) * | 2006-01-26 | 2013-11-29 | Zoetis Services Llc | Nowe kompozycje adiuwantów glikolipidowych |
| GB0608368D0 (en) * | 2006-04-28 | 2006-06-07 | Isis Innovation | Process for making Oligopeptides |
-
2007
- 2007-06-26 AU AU2007264205A patent/AU2007264205B2/en not_active Expired - Fee Related
- 2007-06-26 WO PCT/DK2007/000312 patent/WO2008000261A2/en not_active Ceased
- 2007-06-26 DK DK07764444.1T patent/DK2040745T3/da active
- 2007-06-26 BR BRPI0713978-0A patent/BRPI0713978A2/pt not_active IP Right Cessation
- 2007-06-26 KR KR1020097001606A patent/KR20090024292A/ko not_active Ceased
- 2007-06-26 EP EP11182885A patent/EP2402024A1/en not_active Withdrawn
- 2007-06-26 EP EP11182884A patent/EP2402023A1/en not_active Withdrawn
- 2007-06-26 EP EP07764444A patent/EP2040745B1/en not_active Not-in-force
- 2007-06-26 RU RU2009102389/15A patent/RU2490024C2/ru not_active IP Right Cessation
- 2007-06-26 CA CA002654271A patent/CA2654271A1/en not_active Abandoned
- 2007-06-26 ES ES07764444T patent/ES2400531T3/es active Active
- 2007-06-26 JP JP2009516901A patent/JP5165681B2/ja not_active Expired - Fee Related
- 2007-06-27 US US11/823,402 patent/US8105614B2/en not_active Expired - Fee Related
-
2011
- 2011-12-16 US US13/328,319 patent/US20120156282A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009541373A5 (enExample) | ||
| Kaur et al. | TLR2 agonistic small molecules: detailed structure–activity relationship, applications, and future prospects | |
| US12070498B2 (en) | Conjugate vaccine targeting a disease-causing biological protein | |
| JP5654345B2 (ja) | 多量体マルチエピトープインフルエンザワクチン | |
| CN103747797B (zh) | 脂质体制剂 | |
| EP2200638B1 (en) | Compositions for the transfection of cells | |
| RU2007145052A (ru) | Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера | |
| RU2009102389A (ru) | Расширение спектра клеток для включения субдоминантных эпитопов путем вакцинации с антигенами, доставленными как белковые фрагменты или пептидные коктейли | |
| JP2011512123A5 (enExample) | ||
| JP2011190278A (ja) | 粘膜体表面に接触させてワクチン抗原を包含する物質の効果を調節する新規非抗原性粘膜アジュバント処方 | |
| JP2011518179A5 (enExample) | ||
| JP2003531128A (ja) | 修飾ペプチドを含む医薬調製物 | |
| JP2011525190A (ja) | インフルエンザを処置するための組成物および方法 | |
| JP6158097B2 (ja) | 炎症を抑制するためのペプチド | |
| CN102088992B (zh) | 肽基二酰基甘油酯 | |
| JP7050807B2 (ja) | 新規ペプチドベースのｐｃｓｋ９ワクチン | |
| CN119818665A (zh) | 新型发热伴血小板减少综合征病毒疫苗 | |
| JP2008531463A5 (enExample) | ||
| JPWO2012147805A1 (ja) | 脳移行性機能性核酸及びその利用 | |
| KR20090009839A (ko) | 면역조절 올리고펩티드 | |
| RU2003110420A (ru) | Дифференцирование gnrh-i и gnrh-ii | |
| RU2377249C2 (ru) | Биологически активные производные пептида vapeehptllteaplnpk | |
| JPWO2000051634A1 (ja) | 脂肪酸を構成成分とするワクチン製剤 | |
| CN102178926A (zh) | 预防或治疗肝损伤的肽 | |
| CN121693514A (zh) | 含有Braf肽两亲分子的组合物及其使用方法 |